Growth Metrics

Amicus Therapeutics (FOLD) Goodwill & Intangibles (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Goodwill & Intangibles for 13 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles fell 93.53% year-over-year to $13.9 million, compared with a TTM value of $13.9 million through Dec 2025, down 93.53%, and an annual FY2025 reading of $13.9 million, down 93.53% over the prior year.
  • Goodwill & Intangibles was $13.9 million for Q4 2025 at Amicus Therapeutics, down from $212.5 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $220.8 million in Q1 2021 and bottomed at $13.9 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $188.4 million, with a median of $217.9 million recorded in 2023.
  • The sharpest move saw Goodwill & Intangibles skyrocketed 878.32% in 2024, then plummeted 93.53% in 2025.
  • Year by year, Goodwill & Intangibles stood at $220.8 million in 2021, then changed by 0.0% to $220.8 million in 2022, then decreased by 1.14% to $218.3 million in 2023, then decreased by 1.51% to $215.0 million in 2024, then tumbled by 93.53% to $13.9 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for FOLD at $13.9 million in Q4 2025, $212.5 million in Q3 2025, and $213.4 million in Q2 2025.